Please login to the form below

Not currently logged in
Email:
Password:
From: Sales

AbbVie wins key approval for hep C pill Viekira Pak

US regulator Food and Drug Administrator FDAPrices all-oral treatment fractionally lower than rivals from Gilead

From: Research

Lilly signs $570m deal for next-gen Humalog

Eli Lilly HQLicenses improved version of its insulin blockbuster from Adocia

From: Research

NHS set to deliver 'world-leading' genomics centres

UK Life Sciences Strategy - one year onGenetics research plans could help create more bespoke medicines

From: Sales

Orexigen’s obesity pill Mysimba set for European approval

European Medicines Agency (EMA)But sales of the treatment are only predicted to reach $200m by 2016

Scales

Making success measurable

Companies cannot overlook effective evaluation

Data transparency in Europe

Will 2015 usher in a new era?

Pfizer taps mobile app for patient recruitment

Looks to use smartphone technology to identify rare disease patients

Lannett appoints Teva’s Michael Bogda as president

He served as VP of technical operations in for Teva’s Americas division

Appointment

Creating a 21st century life sciences ecosystem

The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

UK life sciences minister George Freeman

Blue Latitude boosts its team

Appointments follow new business wins for the company

US doctors support digital health technology

Mobile devices and apps find favour in new survey

Pharma iPad detailing doctors physicians

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Regulatory

Complete Regulatory is a specialist medical writing group...

Latest intelligence

UK life sciences minister George Freeman
Creating a 21st century life sciences ecosystem
The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation...
Improving Corporate Memory as a Patient Safety Strategy
An article by Lorri Zipperer...
Online Physician Communities
How can pharma innovate in child and TYA cancer?
by Dr Tim Ringrose, M3 (EU)...